SHAREHOLDER ALERT: Weiss Law Investigates Cardiovascular Systems, Inc.

NEW YORK, Feb. 9, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cardiovascular Systems, Inc. ("Cardiovascular Systems" or the "Company") (NASDAQ: CSII), in connection with the proposed acquisition of the Company by Abbott Laboratories (NYSE: ABT). Under the terms of the merger agreement, the Company's shareholders will receive $20.00 in cash for each share of Cardiovascular Systems owned. The transaction is valued at approximately $890 million. 

Read more at prnewswire.com